文献速递胃肠外科

MRI指导直肠癌TNT后侧方盆腔淋巴结清扫的手术决策

Magnetic Resonance Imaging Directed Surgical Decision Making for Lateral Pelvic Lymph Node Dissection in Rectal Cancer After Total Neoadjuvant Therapy (TNT).
PubMed 文献 · Ann Surg · 2022-07-15

本研究回顾性分析158例TNT前MRI显示侧方盆腔淋巴结肿大的直肠癌患者,经多学科MRI导向决策,56.0%接受侧方盆腔淋巴结清扫。清扫组手术时间更长,但失血量、重大并发症及3年侧方局部复发率无差异。

要点

  • MRI导向多学科决策可筛选TNT后适合侧方淋巴结清扫的直肠癌患者
  • 清扫组与未清扫组3年侧方局部复发率无显著差异
  • 术前淋巴结异质性与边缘不规则、TNT后短径≥5mm与清扫决策相关

核心结论

  • 对于有侧方盆腔淋巴结转移证据的直肠癌患者,多学科MRI导向方法有助于合理选择侧方盆腔淋巴结清扫,围术期与肿瘤学结局无显著差异。

研究设计与样本

  • 回顾性连续队列分析,纳入158例TNT前MRI显示侧方盆腔淋巴结肿大的直肠癌患者,中位随访20个月(IQR 10-32)。

主要发现

  • 88例(56.0%)接受侧方盆腔淋巴结清扫,清扫组总手术时间509分钟 vs 429分钟(P=0.003),但中位失血量(P=0.70)与重大并发症率(19.3% vs 17.0%)无差异。
  • 侧方盆腔淋巴结病理阳性率为34.1%,两组3年侧方局部复发率分别为3.4% vs 4.6%(P=0.85),无显著差异。
  • 术前淋巴结异质性与边缘不规则(OR 3.82,95%CI 1.65-8.82)或TNT后短径≥5mm(OR 2.69,95%CI 1.19-6.08)的患者更可能接受侧方盆腔淋巴结清扫。

临床怎么用

  • 对TNT前MRI显示侧方盆腔淋巴结肿大的直肠癌患者,可采用多学科MRI导向决策选择侧方盆腔淋巴结清扫,不增加重大并发症且局部复发率无差异。

局限性

  • 回顾性设计,中位随访20个月较短,样本量158例,需更长期随访验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Lateral pelvic lymph node (LPLN) metastases are an important cause of preventable local failure in rectal cancer. The aim of this study was to evaluate clinical and oncological outcomes following magnetic resonance imaging (MRI)-directed surgical selection for lateral pelvic lymph node dissection (LPLND) after total neoadjuvant therapy (TNT). METHODS: A retrospective consecutive cohort analysis was performed of rectal cancer patients with enlarged LPLN on pretreatment MRI. Patients were categorized as LPLND or non-LPLND. The main outcomes were lateral local recurrence rate, perioperative and oncological outcomes and factors associated with decision making for LPLND. RESULTS: A total of 158 patients with enlarged pretreatment LPLN and treated with TNT were identified. Median follow-up was 20 months (interquartile range 10-32). After multidisciplinary review, 88 patients (56.0%) underwent LPLND. Mean age was 53 (SD±12) years, and 54 (34.2%) were female. Total operative time (509 vs 429 minutes; P =0.003) was greater in the LPLND group, but median blood loss ( P =0.70) or rates of major morbidity (19.3% vs 17.0%) did not differ. LPLNs were pathologically positive in 34.1%. The 3-year lateral local recurrence rates (3.4% vs 4.6%; P =0.85) did not differ between groups. Patients with LPLNs demonstrating pretreatment heterogeneity and irregular margin (odds ratio, 3.82; 95% confidence interval: 1.65-8.82) or with short-axis ≥5 mm post-TNT (odds ratio 2.69; 95% confidence interval: 1.19-6.08) were more likely to undergo LPLND. CONCLUSIONS: For rectal cancer patients with evidence of LPLN metastasis, the appropriate selection of patients for LPLND can be facilitated by a multidisciplinary MRI-directed approach with no significant difference in perioperative or oncologic outcomes.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Peacock O, Manisundaram N, Dibrito SR, et al. Magnetic Resonance Imaging Directed Surgical Decision Making for Lateral Pelvic Lymph Node Dissection in Rectal Cancer After Total Neoadjuvant Therapy (TNT). Ann Surg. 2022. PMID: 35837891. doi:10.1097/SLA.0000000000005589

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。